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Rare diseases are designated as affecting less than 200,000
individuals (US) and of the approximately 7000 desig-
nated rare diseases, the majority of these occur in pedia-
tric patients, and across international boundaries. An
example is pediatric ARDS (Acute Respiratory Distress
Syndrome) which is not diagnosed until a previously
healthy child presents in the pICU with severe symptoms
and in which more children die each year than from cys-
tic fibrosis and leukemia, combined. The Nathaniel
Adamczyk Foundation (NAF) is focused on identifying
risk factors and opportunities for prevention of this
devastating disease. Boththe diagnosis and patient man-
agement are challenged by having to deal with a syn-
drome in a critical care situation in a heterogeneous
patient population.
NAF has undertaken the development of an (inter)
national tissue and data repository to support both clini-
cal research and enhanced clinical decision support for
patient management. Creation of an analytical platform
to integrate, access and analyze temporal clinical data
ranging from the pICU to also incorporate neo-natal ICU
and pregnancy history is underway with a prototype
already in testing. Analytical methods are being evaluated
in collaboration with Dr. Mike Quasney (Medical College
of Wisconsin) and the Virtual Pediatric ICU and PALISI
(Pediatric Acute Lung Injury and Sepsis Investigators).
This effort is exploring expanded international partner-
ships in both Europe and China to increase the accessible
data for analysis and to further participate in the develop-
ment of better diagnostic standards.
We will present the initial state of both the analytics
and platform development to encourage extension of this
international effort to interested clinicians and clinical
researchers. We believe that this unique approach, which
focuses first on addressing the critical need to improve
patient management through disease stratification, will
not only benefit pARDS but be extensible to many other
pediatric rare disorders.
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